In order to create a comprehensive genomic cancer database, scientists have to reach out to the entire world. Starting with the underserved populations in South Chicago, oncologist Olufunmilayo Olopade began studying the occurrence of BRCA1 and BRCA2 genes in breast cancer around the world. It wasn’t long before she realized that the far-flung human genome will present a variety of complications and proclivities pertaining to each different cancer. Travelling as far as Nigeria for her research, Olopade stresses the need for researchers to also go out and collect the data, rather than waiting for developing countries to catch up.
More from this series: Cancer’s Last Stand
Please read the community guidelines before posting.